| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | — |
| R&D Expense | $81.3M | +32.6% |
| SG&A Expense | $43.6M | +42.0% |
| Operating Income | -$115.0M | -24.8% |
| Interest Expense | $4.6M | +10.2% |
| Pre-tax Income | -$130.5M | -49.3% |
| Income Tax | $185K | — |
| Net Income | -$130.6M | -49.5% |
| EPS (Basic) | -$3.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.8M | +14.0% |
| Current Assets | $95.0M | -33.9% |
| Total Assets | $101.5M | -32.2% |
| Current Liabilities | $31.0M | +17.4% |
| Long-term Debt | $40.7M | +1.6% |
| Total Liabilities | $130.4M | +83.2% |
| Stockholders' Equity | -$28.9M | -150.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.8M | -21.2% |
| Capital Expenditures | $28K | — |
| Investing Cash Flow | $60.0M | +234.9% |
| Financing Cash Flow | $54.8M | -59.2% |
| Free Cash Flow | -$104.8M | — |
| +7.6% |
| EPS (Diluted) | -$3.66 | +6.9% |